Mechanism of apoptotic induction by targeting of GST P and its targeting therapy
Mechanism of apoptotic induction by targeting of GST P and its targeting therapy
批准号:
17591441
负责人:
ASAKURA Tadashi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Treatment of cells with a synthetic conjugate of DXR with GSH via glutaraldehyde (GSH-DXR) caused cytochrome c release from the mitochondria to the cytosol following potent activation of caspase-3 and -9 by typical DNA fragmentation. This apoptosis was regulated by the JNK-signaling pathway. In the present experiment, treatment of cells with GSH-DXR caused deamidation of Bcl-xL, which is localized in mitochondrial membrane. The deamidation of Bcl-xL was disappeared anti-apoptotic function and facilitated the release of cytochrome c from mitochondria. Moreover, GSH-DXR-induced JNK activation caused Bax translocation from cytosol to mitochondria, and also facilitated the release of cytochrome c. Bax was localized as 50-60 kDa Bax-complex with cytosolic protein in cytosol, and dissociated 25 kDa Bax was translocated to mitochondria by GSH-DXR-induced JNK activation. Overexpression of GST-P was suppressed JNK activation and decreased in both Bcl-xL deamidation and Bax translocation. These result were suggested that Bcl-2 family such as Bcl-xL and Bax, acted the induction of apoptosis as target molecule of JNK.When dimethylnitrosamine was injected intraperitoneally to rat, the formation of mini-foci in the liver was observed at two to three weeks after injection. Moreover, foci/nodule was increased at five to six weeks and nodule was formed thereafter. GST-P levels in Foci/nodule was increased extremely at five weeks and decreased gradually thereafter. However, no change in the level of JNK expression in each stage. It was suggested that suppression of JNK activity by GST-P increase in accordance with the formation of Foci/nodule caused to accelerate malignant alteration.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3892/or.14.3.601
发表时间:
2005-09
期刊:
Oncology reports
影响因子:
4.2
作者:
[T. Asakura;Akiko Imai;Noriko Ohkubo-Uraoka;Mayuko Kuroda;Yoko Iidaka;Kumiko Uchida;T. Shibasaki;K. Ohkawa]
通讯作者:
T. Asakura;Akiko Imai;Noriko Ohkubo-Uraoka;Mayuko Kuroda;Yoko Iidaka;Kumiko Uchida;T. Shibasaki;K. Ohkawa
Expression of drug-resistant factor in renal cell cartinoma and overcoming the drug-resistance by treatment with a conjugate of doxorubicin with glutathion
-
批准号:13671675
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:ASAKURA Tadashi
-
依托单位:
海外基金